Belviq (bel-VEEK, lorcaserin) will join Qsymia and other weight loss meds in the battle of the bulge

Belviq (bel-VEEK, lorcaserin) will join Qsymia and other weight loss meds in the battle of the bulge.

Americans spend $60 billion a year trying to lose weight.

The health benefits are significant IF they succeed. Just a 5% to 10% drop in weight can improve blood pressure, lipids, and glucose.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote